Show the full website


CEO leaves cancer firm after six months – in the middle of crucial capital hunt

For the second time in just a year, the biotech firm Inprother bids its CEO farewell, who, like his predecessor, leaves the company after only six months. The CEO departure happens just as the cancer firm hopes to land an investment worth DKK 111m.

Biotech profile Kim Arvid Nielsen leaves the cancer firm Inprother after just six months as its CEO. | Foto: Cytovac/PR

For the second time in just ten months, the startup Inprother loses its top executive.

Firstly, the former Bavarian Nordic executive Mathias Kroll resigned from his position as CEO after just six months, and now Kim Arvid Nielsen, who joined Inprother on April 1, throws in the towel and leaves the post as Inprother's CEO.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Receive newsletter from MedWatch today

NB: Subscribing to the newsletter is free.

More from MedWatch


See all jobs